Navigation Links
Oncothyreon Reports Positive Data from Phase 1 Clinical Trial of PI3-Kinase Inhibitor PX-866 in Patients with Relapsed or Refractory Solid Tumors
Date:11/18/2010

Oncothyreon Reports Positive Data from Phase<br /><font style='display:none'>'/>"/></font></li></ul></table></ol></b></i></a><br /><table border=0 width=520><tr><td>SOURCE Oncothyreon Inc.<br />Copyright©2010 <a href='http://www.prnewswire.com' target='_blank'>PR Newswire.</a><br />All rights reserved</td><td><div class="endSupport"><br /><font id="g_biology_technology_18019">0</font><br /><br /><font class='good' id="c_biology_technology_18019"><a href="javascript:hc('biology_technology','18019')" target="_self">GOOD</a></font></div></td></tr></table><br /><center><b>Page: 1 <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-2/'>2</a> <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-3/'>3</a> <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-4/'>4</a> <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-5/'>5</a> <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-6/'>6</a> <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-7/'>7</a> <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-8/'>8</a> <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-9/'>9</a> <a href='/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-10/'>10</a> </b></center><br /><font color=blue><b><i>Related biology technology :</i></b></font><br /><br /><b>1</b>. <a href='/biology-technology-1/Oncothyreon-Reports-Third-Quarter-2010-Financial-Results-17879-1/'>Oncothyreon Reports Third Quarter 2010 Financial Results</a><br /><b>2</b>. <a href='/biology-technology-1/Oncothyreon-to-Present-at-JMP-Securities-Healthcare-Conference-17412-1/'>Oncothyreon to Present at JMP Securities Healthcare Conference</a><br /><b>3</b>. <a href='/biology-technology-1/ONCOTHYREON-ANNOUNCES-PRICING-OF--2414-9-MILLION-PRIVATE-PLACEMENT-17403-1/'>ONCOTHYREON ANNOUNCES PRICING OF $14.9 MILLION PRIVATE PLACEMENT</a><br /><b>4</b>. <a href='/biology-technology-1/ONCOTHYREON-APPOINTS-JULIE-M--EASTLAND-AS-CHIEF-FINANCIAL-OFFICER-17171-1/'>ONCOTHYREON APPOINTS JULIE M. EASTLAND AS CHIEF FINANCIAL OFFICER</a><br /><b>5</b>. <a href='/biology-technology-1/Oncothyreon-reports-second-quarter-2010-financial-results-17030-1/'>Oncothyreon reports second quarter 2010 financial results</a><br /><b>6</b>. <a href='/biology-technology-1/Oncothyreon-announces-second-quarter-2010-financial-results-conference-call-16951-1/'>Oncothyreon announces second quarter 2010 financial results conference call</a><br /><b>7</b>. <a href='/biology-technology-1/Oncothyreon-announces-presentations-at-upcoming-investor-conferences-in-June-16575-1/'>Oncothyreon announces presentations at upcoming investor conferences in June</a><br /><b>8</b>. <a href='/biology-technology-1/Oncothyreon-to-present-at-the-Rodman--26amp-3B-Renshaw-Annual-Global-Investment-Conference-16273-1/'>Oncothyreon to present at the Rodman & Renshaw Annual Global Investment Conference</a><br /><b>9</b>. <a href='/biology-technology-1/Oncothyreon-reports-full-year-and-fourth-quarter-2009-financial-results-16201-1/'>Oncothyreon reports full year and fourth quarter 2009 financial results</a><br /><b>10</b>. <a href='/biology-technology-1/Oncothyreon-reports-first-quarter-2010-financial-results-16200-1/'>Oncothyreon reports first quarter 2010 financial results</a><br /><b>11</b>. <a href='/biology-technology-1/Oncothyreon-announces-temporary-suspension-of-Stimuvax-clinical-trials-by-Merck-Serono-15943-1/'>Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono</a><br /> </div><script type="text/javascript"><!-- google_ad_client = "ca-pub-8391600731032049"; /* biomed 468x60 */ google_ad_slot = "6344210719"; google_ad_width = 468; google_ad_height = 60; //--> </script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script></div><div id='Comments'><span id='CommentsTopic'>Post Your Comments: <script>document.write("(<a href=# onclick=opcu('technology-1','biology','18019','www.bio-medicine.org/biology-technology-1/Oncothyreon-Reports-Positive-Data-from-Phase-1-Clinical-Trial-of-PI3-Kinase-Inhibitor-PX-866-in-Patients-with-Relapsed-or-Refractory-Solid-Tumors-18019-1/','Oncothyreon%20Reports%20Positive%20Data%20from%20Phase%201%20Clinical%20Trial%20of%20PI3-Kinase%20Inhibitor%20PX-866%20in%20Patients%20with%20Relapsed%20or%20Refractory%20Solid%20Tumors')><font color=#000000>View All Comments</font></a>)")</script></span><div id='CommentsNav'><form name='cfrm' method='post' action='http://www.bio-medicine.org/zjm_comments.asp'><table border=0 cellspacing=0 cellpadding=0><tr><td><table border=0 cellspacing=0 cellpadding=0><tr><td><span style='color:red'>*</span>Name:</td><td><input name='username' style='width:250px'></td></tr><tr><td><span style='color:red'>*</span>Comment:</td><td><TEXTAREA style='WIDTH: 250px; HEIGHT: 78px' name=comment rows='1' cols='20'></TEXTAREA> </td></tr><tr><td><span style='color:red'>*</span>Email:</td><td><input name='email' width='50' style='WIDTH: 250px;'></td></tr><input type=hidden name='index' value='biology'><input type=hidden name='index1' value='technology-1'><input type=hidden name='index_id' value='18019'><tr><td></td><td><input type='submit' name='submit' value=' Submit '> <input type='reset' value=' Reset '></td></tr></form></table></td><td width=20></td><td width=200></td></tr></table></div></div></div><div id='rightColumn'> <div id='dixsw5'><div id='zc10' class='y'>(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ... </div><div id='zc11' class='y'>(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ... </div><div id='zc12' class='y'>(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ... </div><div id='zc13' class='y'>(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ... </div><span id='rightColTopic'><a href='/biology-technology-1/'>Breaking Biology Technology:</a><a id='sy' href='/biology-technology-1/ADM-and-DNA2-0-Enter-Into-Protein-Engineering-Technology-Access-and-Service-Agreement-31420-2/'>ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2</a><a id='sy' href='/biology-technology-1/Velocity-Pharmaceutical-Development--LLC-and-Tigercat-Pharma--Inc--Announce-Phase-2-Results-for-VPD-737-in-Patients-With-Chronic-Pruritus-31415-2/'>Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2</a><a id='sy' href='/biology-technology-1/Velocity-Pharmaceutical-Development--LLC-and-Tigercat-Pharma--Inc--Announce-Phase-2-Results-for-VPD-737-in-Patients-With-Chronic-Pruritus-31415-3/'>Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3</a><a id='sy' href='/biology-technology-1/Velocity-Pharmaceutical-Development--LLC-and-Tigercat-Pharma--Inc--Announce-Phase-2-Results-for-VPD-737-in-Patients-With-Chronic-Pruritus-31415-4/'>Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4</a><a id='sy' href='/biology-technology-1/AeroScout-Founder-Joins-GlassesOffs-Board-of-Directors-31410-2/'>AeroScout Founder Joins GlassesOff's Board of Directors 2</a><a id='sy' href='/biology-technology-1/AeroScout-Founder-Joins-GlassesOffs-Board-of-Directors-31410-3/'>AeroScout Founder Joins GlassesOff's Board of Directors 3</a><a id='sy' href='/biology-technology-1/Maryland-based-Biotech-Company-26-2339-3Bs-Path-Forward-in-Treating-Respiratory-Diseases-Sparks-Name-Change-31405-2/'>Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2</a></span><div id='linkslist1'><a href='/biology-technology-1/ADM-and-DNA2-0-Enter-Into-Protein-Engineering-Technology-Access-and-Service-Agreement-31420-1/' onmousemove=t('c10') onmouseout=r('c10')>[<font color=blue><b>0</b></font>] ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement</a><a href='/biology-technology-1/Velocity-Pharmaceutical-Development--LLC-and-Tigercat-Pharma--Inc--Announce-Phase-2-Results-for-VPD-737-in-Patients-With-Chronic-Pruritus-31415-1/' onmousemove=t('c11') onmouseout=r('c11')>[<font color=blue><b>0</b></font>] Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus</a><a href='/biology-technology-1/AeroScout-Founder-Joins-GlassesOffs-Board-of-Directors-31410-1/' onmousemove=t('c12') onmouseout=r('c12')>[<font color=blue><b>0</b></font>] AeroScout Founder Joins GlassesOff's Board of Directors</a><a href='/biology-technology-1/Maryland-based-Biotech-Company-26-2339-3Bs-Path-Forward-in-Treating-Respiratory-Diseases-Sparks-Name-Change-31405-1/' onmousemove=t('c13') onmouseout=r('c13')>[<font color=blue><b>0</b></font>] Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change</a></div></div><div id='dixsw6'><div id='zc0' class='y'>... Sonia Moralejo Garca at the University of the Basque Country ... and other magnetic devices of wide industrial application. , It ... that are ever smaller and that nanotechnology, although it its ... in our society. Who has not heard of nanotubes, nanoparticles ...</div><div id='zc1' class='y'>... INCREASE 14.6%. Q4 2007 DILUTED EPS UP 20.8% TO $.64. 2008 ... $2.62 PER SHARE., ST. LOUIS, Feb. 12 , HIGHLIGHTS: ... -- Q4 2007 Sales Set New Quarterly Record: At $532.1 ... high, beating the Q2 2007 record of $507.5 ...</div><div id='zc2' class='y'>... of Dow AgroSciences Announces Milestone in Wall Street ... ,Dow AgroSciences LLC and Sangamo BioSciences, Inc. (Nasdaq: ... a key research milestone as part of,their joint ... successful application of Sangamo,s zinc finger DNA-binding,protein nuclease ...</div><span id='rightColTopic'><a href='/biology-technology-1/'>Cached Biology Technology:</a><a id='sy' href='/biology-technology-1/A-researcher-of--UPV-EHU-has-designed-nanomagnets-for-industry-3242-2/'>A researcher of UPV/EHU has designed nanomagnets for industry 2</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-2/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 2</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-3/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 3</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-4/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 4</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-5/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 5</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-6/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 6</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-7/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 7</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-8/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 8</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-9/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 9</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-10/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 10</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-11/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 11</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-12/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 12</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-13/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 13</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-14/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 14</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-15/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 15</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-16/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 16</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-17/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 17</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-18/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 18</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-19/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 19</a><a id='sy' href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-20/'>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark. 20</a><a id='sy' href='/biology-technology-1/Dow-AgroSciences--Sangamo-BioSciences-Announce-the-Achievement-of-Key-Milestone-in-Plant-Agriculture-Collaboration-3238-2/'>Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 2</a><a id='sy' href='/biology-technology-1/Dow-AgroSciences--Sangamo-BioSciences-Announce-the-Achievement-of-Key-Milestone-in-Plant-Agriculture-Collaboration-3238-3/'>Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3</a><a id='sy' href='/biology-technology-1/Dow-AgroSciences--Sangamo-BioSciences-Announce-the-Achievement-of-Key-Milestone-in-Plant-Agriculture-Collaboration-3238-4/'>Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 4</a></span><div id='linkslist1'><a href='/biology-technology-1/A-researcher-of--UPV-EHU-has-designed-nanomagnets-for-industry-3242-1/' onmousemove=t('c0') onmouseout=r('c0')>A researcher of UPV/EHU has designed nanomagnets for industry</a><a href='/biology-technology-1/Sigma-Aldrich--28Nasdaq-3A-SIAL-29-Annual-Sales-Surpass--242-Billion-Mark--3240-1/' onmousemove=t('c1') onmouseout=r('c1')>Sigma-Aldrich (Nasdaq: SIAL) Annual Sales Surpass $2 Billion Mark.</a><a href='/biology-technology-1/Dow-AgroSciences--Sangamo-BioSciences-Announce-the-Achievement-of-Key-Milestone-in-Plant-Agriculture-Collaboration-3238-1/' onmousemove=t('c2') onmouseout=r('c2')>Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration</a></div></div><div id='dixsw1'><div id='zaa10' class='y'>(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in ... seeing a staggering demand from its licensees for highly ... revealed, is not solely coming from fitness and health ... "A wearable is only as useful as ... is the ultimate driver in long-term mass consumer adoption ... </div><div id='zaa11' class='y'>(Date:12/10/2014)... 08, 2014 Research and Markets ... the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of ... rural banking and upgradation of the driver,s license ... the market. Besides the aforementioned projects, biometrics is ... </div><div id='zaa12' class='y'>(Date:12/5/2014)... , Dec. 4, 2014  Tute Genomics, a leader ... million in Series A1 funding led by UK-based Eurovestech. ... participated in the investment round. "We are ... community adopts next-generation sequencing and seeks new approaches for ... Reid Robison , MD MBA, and CEO of Tute ... </div><span id='rightColTopic'><a href='/biology-news-1/'>Breaking Biology News(10 mins):</a><a id='sy' href='/biology-news-1/Wearable-Technology-Products-Demand-Highly-Accurate-Biometric-Technology-38555-2/'>Wearable Technology Products Demand Highly Accurate Biometric Technology 2</a><a id='sy' href='/biology-news-1/Biometrics-Market-in-Japan-2014-2018-3A-Key-Vendors-are-DDS--Fujitsu--Hitachi-and-NEC-38552-2/'>Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2</a><a id='sy' href='/biology-news-1/Tute-Genomics-Raises--242-3-Million-to-Scale-Up-Cloud-Based-Genome-Analytics-and-Accelerate-Personalized-Medicine-38549-2/'>Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2</a><a id='sy' href='/biology-news-1/Tute-Genomics-Raises--242-3-Million-to-Scale-Up-Cloud-Based-Genome-Analytics-and-Accelerate-Personalized-Medicine-38549-3/'>Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3</a></span><div id='linkslist1'><a href='/biology-news-1/Wearable-Technology-Products-Demand-Highly-Accurate-Biometric-Technology-38555-1/' onmousemove=t('aa10') onmouseout=r('aa10')>[<font color=blue><b>0</b></font>] Wearable Technology Products Demand Highly Accurate Biometric Technology</a><a href='/biology-news-1/Biometrics-Market-in-Japan-2014-2018-3A-Key-Vendors-are-DDS--Fujitsu--Hitachi-and-NEC-38552-1/' onmousemove=t('aa11') onmouseout=r('aa11')>[<font color=blue><b>0</b></font>] Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC</a><a href='/biology-news-1/Tute-Genomics-Raises--242-3-Million-to-Scale-Up-Cloud-Based-Genome-Analytics-and-Accelerate-Personalized-Medicine-38549-1/' onmousemove=t('aa12') onmouseout=r('aa12')>[<font color=blue><b>0</b></font>] Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine</a></div></div><div id='dixsw3'><div id='za0' class='y'>... the northwest coast of North America is reaching the level ... study led by a researcher at the University of British ... Marine Pollution Bulletin , examined stomach contents of beached northern ... states of Washington and Oregon, U.S.A. "Like the canary ...</div><div id='za1' class='y'>... 3, 2012 From solar energy to water treatment, ... "sustainability" is more than just a buzzword. ... Council of Canada (NSERC) announced that Concordia had received ... an Institute in Water, Energy and Sustainability. Not only ...</div><div id='za2' class='y'>... COLUMBIA, Mo. The most common ailment to affect a ... has developed a way to detect this problem using a ... Keegan, a professor of equine surgery in the College of ... can detect lameness earlier than veterinarians using the traditional method ...</div><span id='rightColTopic'><a href='/biology-news-1/'>Cached Biology News:</a><a id='sy' href='/biology-news-1/Seabirds-study-shows-plastic-pollution-reaching-surprising-levels-off-coast-of-Pacific-Northwest-25682-2/'>Seabirds study shows plastic pollution reaching surprising levels off coast of Pacific Northwest 2</a><a id='sy' href='/biology-news-1/-241-6-million-for-sustainability-25677-2/'>$1.6 million for sustainability 2</a><a id='sy' href='/biology-news-1/Motion-sensors-detect-horse-lameness-earlier-than-veterinarians--MU-study-finds-25672-2/'>Motion sensors detect horse lameness earlier than veterinarians, MU study finds 2</a></span><div id='linkslist1'><a href='/biology-news-1/Seabirds-study-shows-plastic-pollution-reaching-surprising-levels-off-coast-of-Pacific-Northwest-25682-1/' onmousemove=t('a0') onmouseout=r('a0')>Seabirds study shows plastic pollution reaching surprising levels off coast of Pacific Northwest</a><a href='/biology-news-1/-241-6-million-for-sustainability-25677-1/' onmousemove=t('a1') onmouseout=r('a1')>$1.6 million for sustainability</a><a href='/biology-news-1/Motion-sensors-detect-horse-lameness-earlier-than-veterinarians--MU-study-finds-25672-1/' onmousemove=t('a2') onmouseout=r('a2')>Motion sensors detect horse lameness earlier than veterinarians, MU study finds</a></div></div><div id='dixsw4'><div id='zb0' class='y'>RABBIT ANTI HUMAN TRRAP (CT) Immunogen: Recombinant C-terminal kinase-related domain of human TRRAP....</div><div id='zb1' class='y'>...</div><div id='zb2' class='y'>SHEEP ANTI DEHYDROEPIANDROSTERONE...</div><div id='zb3' class='y'>... by N.C. Price (1996) • ... on protein chemistry and the ... proteins. Data on the following ... size determination, amino acid analysis ...</div><span id='rightColTopic'><a href='/biology-products/'>Biology Products:</a></span><div id='linkslist1'><a href='/biology-products/Rabbit-Anti-Human-TRRAP-C-Terminal-Polyclonal-Antibody--Unconjugated-from-AbD-Serotec-4642-1/' onmousemove=t('b0') onmouseout=r('b0')>Rabbit Anti-Human TRRAP C-Terminal Polyclonal Antibody, Unconjugated from AbD Serotec</a><a href='/biology-products/Pyrophosphate-Colorimetric---Fluorometric--28resorufin-29-Assay-Kit--PiPer--from-Molecular-Probes--28Invitrogen-29-4637-1/' onmousemove=t('b1') onmouseout=r('b1')>Pyrophosphate Colorimetric / Fluorometric (resorufin) Assay Kit, PiPer from Molecular Probes (Invitrogen)</a><a href='/biology-products/Sheep-Anti-DEHYDROEPIANDROSTERONE--28+DEAHS-29-Polyclonal-Antibody--Unconjugated-from-AbD-Serotec-4632-1/' onmousemove=t('b2') onmouseout=r('b2')>Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec</a><a href='/biology-products/Proteins-LabFax-from-Promega-4627-1/' onmousemove=t('b3') onmouseout=r('b3')>Proteins LabFax from Promega</a></div></div><div id='edli' style='display:none;'><span id='leftColTopic'>Biology Navigation</span><div id='leftax'><ul id='leftall'><li><a href='/biology.asp?s=AIDS/HIV&w=AIDS-HIV'>AIDS/HIV</a></li><li><a href='/biology.asp?s=Bioinformatics&w=Bioinformatics'>Bioinformatics</a></li><li><a href='/biology.asp?s=Biotechnology&w=Biotech'>Biotechnology</a></li><li><a href='/biology.asp?s=Biochemistry&w=chemis'>Biochemistry</a></li><li><a href='/biology.asp?s=Cancer&w=Cancer'>Cancer</a></li><li><a href='/biology.asp?w=Cell%20&s=Cell%20Biology'>Cell Biology</a></li><li><a href='/biology.asp?s=Developmental%20Biology&w=Developme'>Developmental Biology</a></li><li><a href='/biology.asp?s=Ecology&w=Ecology'>Ecology</a></li><li><a href='/biology.asp?s=Environment&w=Environment'>Environment</a></li><li><a href='/biology.asp?s=Evolution&w=Evolution'>Evolution</a></li><li><a href='/biology.asp?w=%20Food%20&s=Food%20Technology'>Food Technology</a></li><li><a href='/biology.asp?s=Gene&w=Gene'>Gene</a></li><li><a href='/biology.asp?s=Genetics&w=Genetic'>Genetics</a></li><li><a href='/biology.asp?s=Genomics&w=Genomic'>Genomics</a></li><li><a href='/biology.asp?s=Health/Medicine&w=Health-Medicine-medical'>Health/Medicine</a></li><li><a href='/biology.asp?s=Immunology&w=Immun'>Immunology</a></li><li><a href='/biology.asp?s=Microarray&w=Microarray'>Microarray</a></li><li><a href='/biology.asp?s=Microbiology&w=Microbiology'>Microbiology</a></li><li><a href='/biology.asp?s=Molecular&w=Molecular'>Molecular</a></li><li><a href='/biology.asp?s=Marine%20Biology&w=Marine'>Marine Biology</a></li><li><a href='/biology.asp?s=Nanobiotechnology&w=Nano'>Nanobiotechnology</a></li><li><a href='/biology.asp?s=Neurobiology&w=Neuro'>Neurobiology</a></li><li><a href='/biology.asp?s=Plant%20Sciences&w=Plant'>Plant Sciences</a></li><li><a href='/biology.asp?s=Stem%20Cell&w=Stem%20Cell'>Stem Cell</a></li><li><a href='/biology.asp?s=Systems%20Biology&w=System'>Systems Biology</a></li><li><a href='/biology.asp?s=Virus&w=Virus'>Virus</a></li><li><a href='/biology.asp?s=Women%20Health&w=Women'>Women Health</a></li></ul></div><span id='leftColTopic'>Medical Navigation</span><div id='leftax'><ul id='leftall'><li><a href='/medicine.asp?s=Abortion&w=Abortion'>Abortion</a></li><li><a href='/medicine.asp?s=Aches&w=Ache'>Aches</a></li><li><a href='/medicine.asp?s=ADHD&w=ADHD'>ADHD</a></li><li><a href='/medicine.asp?s=Addiction&w=Addiction'>Addiction</a></li><li><a href='/medicine.asp?s=Alcohol&w=Alcohol'>Alcohol</a></li><li><a href='/medicine.asp?s=Allergy&w=Allergy'>Allergy</a></li><li><a href='/medicine.asp?s=Alternative%20Medicine&w=Alternative'>Alternative Medicine</a></li><li><a href='/medicine.asp?s=Alzheimer%27s%20Dementia&w=Alzheimer'>Alzheimer's Dementia</a></li><li><a href='/medicine.asp?s=Anxiety/Stress&w=Anxiety-Stress'>Anxiety/Stress</a></li><li><a href='/medicine.asp?s=Arthritis&w=Arthritis'>Arthritis</a></li><li><a href='/medicine.asp?s=Autism&w=Autism'>Autism</a></li><li><a href='/medicine.asp?s=Bacteria&w=Bacteria'>Bacteria</a></li><li><a href='/medicine.asp?s=Blood&w=Blood'>Blood</a></li><li><a href='/medicine.asp?s=Bird%20Flu/Avian%20Flu&w=Bird%20Flu-Avian%20Flu'>Bird Flu/Avian Flu</a></li><li><a href='/medicine.asp?s=Bones&w=Bone'>Bones</a></li><li><a href='/medicine.asp?s=Breast%20Cancer&w=Breast%20Cancer'>Breast Cancer</a></li><li><a href='/medicine.asp?s=Cancer&w=Cancer'>Cancer</a></li><li><a href='/medicine.asp?s=Cardiovascular&w=Cardiovascular'>Cardiovascular</a></li><li><a href='/medicine.asp?s=Cervical%20Cancer&w=Cervical%20Cancer'>Cervical Cancer</a></li><li><a href='/medicine.asp?s=Chikungunya&w=Chikungunya'>Chikungunya</a></li><li><a href='/medicine.asp?s=Cholesterol&w=Cholesterol'>Cholesterol</a></li><li><a href='/medicine.asp?s=Clinical%20Trials&w=Clinical'>Clinical Trials</a></li><li><a href='/medicine.asp?s=Colorectal%20Cancer&w=Colorectal%20Cancer'>Colorectal Cancer</a></li><li><a href='/medicine.asp?s=Conferences&w=Conference'>Conferences</a></li><li><a href='/medicine.asp?s=Crohn%27s&w=Crohn'>Crohn's</a></li><li><a href='/medicine.asp?s=Cystic%20Fibrosis&w=Fibrosis'>Cystic Fibrosis</a></li><li><a href='/medicine.asp?s=Dengue&w=Dengue'>Dengue</a></li><li><a href='/medicine.asp?s=Dentistry&w=Dentis-Dental'>Dentistry</a></li><li><a href='/medicine.asp?s=Depression&w=Depression'>Depression</a></li><li><a href='/medicine.asp?s=Diabetes&w=Diabetes'>Diabetes</a></li><li><a href='/medicine.asp?s=Drug&w=Drug'>Drug</a></li><li><a href='/medicine.asp?s=Eating%20Disorders&w=Eating-Disorder'>Eating Disorders</a></li><li><a href='/medicine.asp?s=Education&w=Education'>Education</a></li><li><a href='/medicine.asp?s=Epilepsy&w=Epilepsy'>Epilepsy</a></li><li><a href='/medicine.asp?s=Erectile%20Dysfunction&w=Erectile%20Dysfunction'>Erectile Dysfunction</a></li><li><a href='/medicine.asp?s=Eye%20Health/Blindness&w=Eye%20-Blindness'>Eye Health/Blindness</a></li><li><a href='/medicine.asp?s=Fertility&w=Fertility'>Fertility</a></li><li><a href='/medicine.asp?s=Flu/Cold&w=Flu%20-Cold'>Flu/Cold</a></li><li><a href='/medicine.asp?s=GastroIntestinal&w=Gastro'>GastroIntestinal</a></li><li><a href='/medicine.asp?s=Genetics&w=Genetic'>Genetics</a></li><li><a href='/medicine.asp?s=Gout&w=Gout'>Gout</a></li><li><a href='/medicine.asp?s=Headache/Migraine&w=Headache-Migraine'>Headache/Migraine</a></li><li><a href='/medicine.asp?s=Hearing/Deafness&w=Hearing-Deafness'>Hearing/Deafness</a></li><li><a href='/medicine.asp?s=HIV/AIDS&w=HIV/AIDS'>HIV/AIDS</a></li><li><a href='/medicine.asp?s=Huntington%27s%20Disease&w=Huntington'>Huntington's Disease</a></li><li><a href='/medicine.asp?s=Hypertension&w=Hypertension'>Hypertension</a></li><li><a href='/medicine.asp?s=Immune%20System/Vaccines&w=Immune-Vaccine'>Immune System/Vaccines</a></li><li><a href='/medicine.asp?s=Insurance&w=Insurance'>Insurance</a></li><li><a href='/medicine.asp?s=Infectious%20Diseases&w=Infectious'>Infectious Diseases</a></li><li><a href='/medicine.asp?s=Irritable-Bowel%20Syndrome&w=Bowel'>Irritable-Bowel Syndrome</a></li><li><a href='/medicine.asp?s=Internet&w=Internet'>Internet</a></li><li><a href='/medicine.asp?s=Leukemia&w=Leukemia'>Leukemia</a></li><li><a href='/medicine.asp?s=Lifestyle&w=Lifestyle'>Lifestyle</a></li><li><a href='/medicine.asp?s=Liver%20Disease/Hepatitis&w=%20Liver%20-Hepatitis'>Liver Disease/Hepatitis</a></li><li><a href='/medicine.asp?s=Lung%20Cancer&w=Lung%20Cancer'>Lung Cancer</a></li><li><a href='/medicine.asp?s=Lupus&w=Lupus'>Lupus</a></li><li><a href='/medicine.asp?s=Mad%20Cow%20Disease&w=Mad%20Cow'>Mad Cow Disease</a></li><li><a href='/medicine.asp?s=Medical%20Devices&w=Device'>Medical Devices</a></li><li><a href='/medicine.asp?s=Medical%20Students/Training&w=Student-Training'>Medical Students/Training</a></li><li><a href='/medicine.asp?s=Medicare/Medicaid&w=Medicare-Medicaid'>Medicare/Medicaid</a></li><li><a href='/medicine.asp?s=Medico&w=Medico'>Medico</a></li><li><a href='/medicine.asp?s=Men%27s%20health&w=%20Men%20-%20Men%27%27s'>Men's health</a></li><li><a href='/medicine.asp?s=Mental%20Health&w=Mental'>Mental Health</a></li><li><a href='/medicine.asp?s=MRI/Ultrasound&w=MRI-Ultrasound'>MRI/Ultrasound</a></li><li><a href='/medicine.asp?s=MRSA/Drug%20Resistance&w=MRSA-Resistance'>MRSA/Drug Resistance</a></li><li><a href='/medicine.asp?s=Multiple%20Sclerosis&w=Sclerosis'>Multiple Sclerosis</a></li><li><a href='/medicine.asp?s=Muscular%20Dystrophy&w=Muscular%20Dystrophy'>Muscular Dystrophy</a></li><li><a href='/medicine.asp?s=Neurology&w=Neuro'>Neurology</a></li><li><a href='/medicine.asp?s=Nursing&w=Nursing'>Nursing</a></li><li><a href='/medicine.asp?s=Nutrition/Diet&w=Nutrition-Diet'>Nutrition/Diet</a></li><li><a href='/medicine.asp?s=Obesity/Weight%20Loss&w=Obesity-Weight%20Loss'>Obesity/Weight Loss</a></li><li><a href='/medicine.asp?s=Pain/Anesthetics&w=Pain-Anesthetic'>Pain/Anesthetics</a></li><li><a href='/medicine.asp?s=Parkinson%27s%20Disease&w=Parkinson'>Parkinson's Disease</a></li><li><a href='/medicine.asp?s=Pediatrics/Children%27s%20Health&w=Pediatric-Children'>Pediatrics/Children's Health</a></li><li><a href='/medicine.asp?s=Pharma/Biotech%20Industry&w=Pharma-Biotech'>Pharma/Biotech Industry</a></li><li><a href='/medicine.asp?s=Pharmacy/Pharmacists&w=Pharmac'>Pharmacy/Pharmacists</a></li><li><a href='/medicine.asp?s=Pregnancy&w=Pregnancy'>Pregnancy</a></li><li><a href='/medicine.asp?s=Premature&w=Premature'>Premature</a></li><li><a href='/medicine.asp?s=Prostate&w=Prostate'>Prostate</a></li><li><a href='/medicine.asp?s=Psychology/Psychiatry&w=Psych'>Psychology/Psychiatry</a></li><li><a href='/medicine.asp?s=Rehabilitation&w=Rehabilit'>Rehabilitation</a></li><li><a href='/medicine.asp?s=Respiratory/Asthma&w=Respiratory-Asthma'>Respiratory/Asthma</a></li><li><a href='/medicine.asp?s=SARS&w=SARS'>SARS</a></li><li><a href='/medicine.asp?s=Schizophrenia&w=Schizophrenia'>Schizophrenia</a></li><li><a href='/medicine.asp?s=Seniors/Aging&w=Senior-%20Aging'>Seniors/Aging</a></li><li><a href='/medicine.asp?s=Sexual%20Health&w=Sexual'>Sexual Health</a></li><li><a href='/medicine.asp?s=Sleep/Sleep%20Disorders&w=Sleep'>Sleep/Sleep Disorders</a></li><li><a href='/medicine.asp?s=Smoking&w=Smoking'>Smoking</a></li><li><a href='/medicine.asp?s=Statins&w=Statins'>Statins</a></li><li><a href='/medicine.asp?s=Stem%20Cell%20Research&w=Stem%20Cell'>Stem Cell Research</a></li><li><a href='/medicine.asp?s=Stroke&w=Stroke'>Stroke</a></li><li><a href='/medicine.asp?s=Surgery&w=Surgery'>Surgery</a></li><li><a href='/medicine.asp?s=Transplants/Organ%20Donations&w=Transplants-Donation'>Transplants/Organ Donations</a></li><li><a href='/medicine.asp?s=Viruses&w=Virus'>Viruses</a></li><li><a href='/medicine.asp?w=Water-%20Air%20&s=Water%20-%20Air%20Quality'>Water - Air Quality</a></li><li><a href='/medicine.asp?s=Women%27s%20Health&w=Women'>Women's Health</a></li></ul></div></div></div><div id='footer'><table border='0' width='100%'><tr><td align='left'>Copyright © 2003-2012 Bio-Medicine. All rights reserved.<br /><a href='/?q=about_index.html'>ABOUT</a> | <a href='/?q=contact_index.html'>CONTACT US</a> | <a href='/?q=DISCLAIMER_index.html'>DISCLAIMER</a> | <a href='/?q=PrivacyPolicy_index.html'>PRIVACY POLICY</a> | <a href='/?q=TermsAndConditions_index.html'>TERMS AND CONDITIONS</a><br /></td><td align='right'><a href='/'><img src='http://img.bio-medicine.org/images/dbtn.gif' border='0' alt='latest biology and medical news/technology'/></a></td></tr></table></div></div><script type='text/javascript'>document.write('<scr'+'ipt type=\'text/javascript\' src=\'http://js.bio-medicine.org/inc/zjm_cls4.asp?rf='+escape(document.referrer)+'\'></scr'+'ipt>')</script><script src='http://css.bio-medicine.org/images/gdbm.js'></script> <script type="text/javascript"> (function() { var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true; po.src = 'https://apis.google.com/js/plusone.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s); })(); </script> <script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script> <script type="text/javascript"> _uacct = "UA-2054987-1"; urchinTracker(); </script> </body></html>